MedPath

To compare and analyse the effect of Nigella sativa oil as an add-on therapy in addition to alpha Keto analogue of essential amino acids, in the conservative management of Chronic Kidney Disease

Phase 4
Completed
Conditions
Health Condition 1: null- Chronic Kidney Disease
Registration Number
CTRI/2018/01/011429
Lead Sponsor
JN medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

1.Chronic kidney disease of different etiology, before ESRD.

2.Patient not on any renal replacement therapy.

3.Age Ë? 18 years.

Exclusion Criteria

1.Acute on Chronic Kidney Disease.

2.Pregnancy.

3.Psychotic patients.

4.Critically ill patients.

5.HIV/HBsAg /Anti-HCV and immune-compromised patients.

Patient on any form of Renal Replacement Therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Haemogram <br/ ><br>2.Blood Glucose- Fasting & Post Prandial <br/ ><br>3.Total Urine Protein (TUP) in 24 hour sample. <br/ ><br>4.Blood Urea <br/ ><br>5.Serum Creatinine <br/ ><br>6.Estimated GFR(ml/min per 1.73 m2) <br/ ><br>7.Serum Ca++ <br/ ><br>8.Serum Electrolytes ( Na+ , K+ )Timepoint: 0,4,8 and 12 weeks
Secondary Outcome Measures
NameTimeMethod
1.LFT <br/ ><br>2.LIPID PROFILE <br/ ><br>3.USG ABDOMENTimepoint: 0 and 12 weeks
© Copyright 2025. All Rights Reserved by MedPath